Schellekens, Arnt

The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder

Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews

Attention Deficit Hyperactivity DisorderAutism Spectrum Disorder Research

Cited by 1,545

Disruption of Reward Processing in Addiction: An Image-Based Meta-analysis of Functional Magnetic Resonance Imaging Studies

Luijten, M., Schellekens, A. F., Kühn, S., Machielse, M. W. J., & Sescousse, G. (2017) · JAMA Psychiatry

Neurotransmitter Receptor Influence on BehaviorGambling Behavior and Treatments

Cited by 402

Therapeutic effect of psilocybin in addiction: A systematic review

van der Meer, P. B., Fuentes, J. J., Kaptein, A. A., Schoones, J. W., de Waal, M. M., Goudriaan, A. E., Kramers, K., Schellekens, A., Somers, M., Bossong, M. G., et al. (2023) · Frontiers in Psychiatry

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 127

Establishing the dopamine dependency of human striatal signals during reward and punishment reversal learning

van der Schaaf, M. E., van Schouwenburg, M. R., Geurts, D. E. M., Schellekens, A. F. A., Buitelaar, J. K., Verkes, R. J., & Cools, R. (2014) · Cerebral Cortex

Neurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology Studies

Cited by 102

Discontinuation of psychotropic medication: a synthesis of evidence across medication classes.

Vinkers, C. H., Kupka, R. W., Penninx, B. W., Ruhé, H. G., van Gaalen, J. M., van Haaren, P. C. F., Schellekens, A. F. A., Jauhar, S., Ramos-Quiroga, J. A., Vieta, E., et al. (2024) · Molecular Psychiatry

Treatment of Major DepressionBipolar Disorder and Treatment

Cited by 51

Cognitive Functioning in Long-Term Benzodiazepine Users

Zetsen, S. P. G., Schellekens, A. F. A., Paling, E. P., Kan, C. C., & Kessels, R. P. C. (2022) · European Addiction Research

Pharmaceutical Practices and Patient OutcomesSubstance Abuse Treatment and Outcomes

Cited by 47

Treatment of Adolescents with Concurrent Substance Use Disorder and Attention-Deficit/Hyperactivity Disorder: A Systematic Review

Özgen, H., Spijkerman, R., Noack, M., Holtmann, M., Schellekens, A., Dalsgaard, S., van den Brink, W., & Hendriks, V. (2021) · Journal of Clinical Medicine

Attention Deficit Hyperactivity DisorderSubstance Abuse Treatment and Outcomes

Cited by 27

Relating addiction and psychiatric disorders

Vink, J. M., & Schellekens, A. (2018) · Science

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 22

Neurodevelopmental and behavioral consequences of perinatal exposure to the HIV drug efavirenz in a rodent model

van de Wijer, L., Garcia, L. P., Hanswijk, S. I., Rando, J., Middelman, A., ter Heine, R., Mast, Q. D., Martens, G. J. M., van der Ven, A. J. A. M., Kolk, S. M., et al. (2019) · Translational Psychiatry

Prenatal Substance Exposure EffectsPharmacological Effects and Toxicity Studies

Cited by 13

Perinatal exposure of rats to the HIV drug efavirenz affects medial prefrontal cortex cytoarchitecture

Garcia, L. P., Van de Wijer, L., Hanswijk, S. I., Rando, J., Witteveen, J. S., Middelman, A., ter Heine, R., de Mast, Q., Martens, G. J. M., van der Ven, A. J. A. M., et al. (2020) · Biochemical Pharmacology

Prenatal Substance Exposure EffectsHIV/AIDS drug development and treatment

Cited by 6

Mindfulness-based cognitive therapy for chronic noncancer pain and prescription opioid use disorder: A qualitative pilot study of its feasibility and the perceived process of change

Ellerbroek, H., Hanssen, I., Lathouwers, K., Cillessen, L., Dekkers, S., Veldman, S. E., van den Heuvel, S. A. S., Speckens, A. E. M., & Schellekens, A. F. A. (2023) · Brain and Behavior

Mindfulness and Compassion InterventionsOpioid Use Disorder Treatment

Cited by 5